Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REDPINE: Remdesivir in COVID-19 with Reduced Kidney Function
NCT04745351Phase 3Terminated
- Sponsor
- Gilead Sciences
- Start
- Mar 2021
- Primary completion
- Apr 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 6
01
Overview
A Phase 3 trial of remdesivir in coronavirus disease 2019 (COVID-19), sponsored by Gilead Sciences. Started Mar 2021; status: terminated.
02
Drugs
remdesivir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04745351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04745351.